ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
4,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
10,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
12,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
13,1,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
14,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
16,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
18,1,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
19,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Migraine,Migraine headaches,Headaches,Nerv,N
21,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
22,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
22,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
23,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
24,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
25,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
26,1,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
26,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
27,1,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
28,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
28,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
29,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Headache,Headaches NEC,Headaches,Nerv,N
35,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
36,1,Hypoplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
37,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
38,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
39,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
39,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
39,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
40,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Rash follicular,Pustular conditions,Epidermal and dermal conditions,Skin,N
42,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
43,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
43,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
44,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
45,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
45,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
45,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
45,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
46,1,Application site scar,Application site reactions,Administration site reactions,Genrl,N
47,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
47,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
47,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
48,1,Accidental poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
48,2,Anticholinergic syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
49,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
50,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
50,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
51,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
51,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
51,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
52,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
53,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
53,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
53,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
53,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
54,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
55,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
55,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
55,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,4,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
56,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
56,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
56,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
56,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
56,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
57,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
57,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
57,4,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
57,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
57,6,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
59,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
59,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
59,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
60,1,Acne,Acnes,Skin appendage conditions,Skin,N
